Neck dissection following chemoradiation for node positive head and neck carcinomas;Place du curage ganglionnaire après chimioradiothérapie dans les carcinomes épidermoïdes des voies aérodigestives supérieures avec atteinte ganglionnaire initiale (nasopharynx exclu)

Cancer/Radiotherapie

Volumn 13, Issue 8, 2009, Pages 758-770

  Thariat, J ^a,b,c   Hamoir, M ^d   Janot, F ^e   De Mones, E ^f   Marcy, P Y ^a,c   Carrier, P ^g   Bozec, A ^a,c   Guevara, N ^h   Albert, S ⁱ   Vedrine, P O ^j   Graff, P ^k   Peyrade, F ^a,c   Hofman, P ^c,g   Santini, J ^h   Bourhis, J ^e   Lapeyre, M ^l  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b CENTRE DE BIOCHIMIE   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF NICE   (France)

^h PASTEUR HOSPITAL   (France)

ⁱ BICHAT HOSPITAL   (France)

^j CHG Cannes   (France)

^k CENTRE ALEXIS VAUTRIN   (France)

^l Centre Regional de Lutte Contre le Cancer Jean Perrin   (France)

more..

Author keywords

Adenopathy; Chemoradiation; Neck dissection; Node; Pathologic response; Positron emission tomography (PET); Regional control; Scanner; Squamous cell carcinoma; Viable tumor

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LYMPH NODE METASTASIS; LYMPHADENOPATHY; NECK DISSECTION; OROPHARYNX CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT RESPONSE;

CHEMOTHERAPY, ADJUVANT; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NECK DISSECTION; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 73049115216     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2009.05.005     Document Type: Short Survey

References (99)

1. Ahlberg A., Lagerlund M., Lewin F., Friesland S., and Lundgren J. Clinical outcome following radiotherapy and planned neck dissection in N+ head and neck cancer patients. Acta Otolaryngol 128 12 (2008) 1354-1360
2. Ahmed K.A., Robbins K.T., Wong F., and Salazar J.E. Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Laryngoscope 110 (2000) 1789-1793
3. Argiris A., Stenson K.M., Brockstein B.E., Mittal B.B., Pelzer H., Kies M.S., et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 26 (2004) 447-455
4. Ballonoff A., Raben D., Rusthoven K.E., Bassetti M., Kane M., Song J.I., et al. Outcomes of patients with n3 neck nodes treated with chemoradiation. Laryngoscope 118 (2008) 995-998
5. Bataini J.P., Bernier J., Brugere J., Jaulerry C., Picco C., and Brunin F. Natural history of neck disease in patients with squamous cell carcinoma of oropharynx and pharyngolarynx. Radiother Oncol 3 (1985) 245-255
6. Bataini J.P., Bernier J., Jaulerry C., Brunin F., Pontvert D., and Lave C. Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy. Int J Radiat Oncol Biol Phys 13 (1987) 817-824
7. Bonnen M.D., Ballo M.T., Myers J.N., Garden A.S., Diaz Jr. E.M., Gershenwald J.E., et al. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer 100 (2004) 383-389
8. Boyd T.S., Harari P.M., Tannehill S.P., Voytovich M.C., Hartig G.K., Ford C.N., et al. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 20 (1998) 132-137
9. Brizel D.M., Prosnitz R.G., Hunter S., Fisher S.R., Clough R.L., Downey M.A., et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1418-1423
10. Brown K.M., Lango M., and Ridge J.A. The role of neck dissection in the combined modality therapy setting. Semin Oncol 35 (2008) 229-235
11. Buntzel J., Hornig A., Glatzel M., Micke O., Bruns F., Schafer U., et al. Tumor markers and lymphatic metastasis in head and neck cancer patients. Anticancer Res 25 (2005) 1539-1542
12. Byers R.M., Clayman G.L., Guillamondequi O.M., Peters L.J., and Goepfert H. Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract. Head Neck 14 (1992) 133-138
13. Calais G., Alfonsi M., Bardet E., Sire C., Germain T., Bergerot P., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91 (1999) 2081-2086
14. Canning C.A., Gubbels S., Chinn C., Wax M., and Holland J.M. Positron emission tomography scan to determine the need for neck dissection after chemoradiation for head and neck cancer: timing is everything. Laryngoscope 115 (2005) 2206-2208
15. Chan A.W., Ancukiewicz M., Carballo N., Montgomery W., and Wang C.C. The role of postradiotherapy neck dissection in supraglottic carcinoma. Int J Radiat Oncol Biol Phys 50 (2001) 367-375
16. Clayman G.L., Johnson C.J., 2nd, Morrison W., Ginsberg L., and Lippman S.M. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 127 (2001) 135-139
17. Corry J., Peters L., Fisher R., Macann A., Jackson M., McClure B., et al. N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98, 02. Head Neck 30 (2008) 737-742
18. Corry J., Rischin D., Smith J.G., D'Costa I.A., Huges P.G., Sexton M.A., et al. Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer. Radiother Oncol 54 (2000) 123-127
19. Crile G. Landmark article Dec 1, 1906. Excision of cancer of the head and neck. With special reference to the plan of dissection based on one hundred and thirty-two operations by George. Crile. Jama 258 (1987) 3286-3293
20. Davidson B.J., Newkirk K.A., Harter K.W., Picken C.A., Cullen K.J., and Sessions R.B. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 125 (1999) 401-405
21. de Bondt R.B., Nelemans P.J., Bakers F., Casselman J.W., Peutz-Kootstra C., Kremer B., et al. Morphological MRI criteria improve the detection of lymph node metastases in head and neck squamous cell carcinoma: multivariate logistic regression analysis of MRI features of cervical lymph nodes. Eur Radiol 19 3 (2009) 626-633
22. Dequanter D., Lothaire P., Awada A., Lalami Y., Hien Nguyen T., Lemort M., et al. Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?. Acta Otolaryngol 126 (2006) 1225-1228
23. Dequanter D., Lothaire P., Bourgeois P., Flamen P., Lemort M., and Andry G. Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck cancer: preliminary results. Acta Chir Belg 106 (2006) 519-522
24. Doweck I., Robbins K.T., Mendenhall W.M., Hinerman R.W., Morris C., and Amdur R. Neck level-specific nodal metastases in oropharyngeal cancer: is there a role for selective neck dissection after definitive radiation therapy?. Head Neck 25 (2003) 960-967
25. Dubray B.M., Bataini J.P., Bernier J., Thames H.D., Lave C., Asselain B., et al. Is reseeding from the primary a plausible cause of node failure?. Int J Radiat Oncol Biol Phys 25 (1993) 9-15
26. Ensley J.F., Jacobs J.R., Weaver A., Kinzie J., Crissman J., Kish J.A., et al. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54 (1984) 811-814
27. Ferlito A., and Rinaldo A. Is radical neck dissection a current option for neck disease?. Laryngoscope 118 (2008) 1717-1718
28. Ferlito A., Silver C.E., Shaha A.R., and Rinaldo A. Management of N3 neck. Acta Otolaryngol 122 (2002) 230-233
29. Fletcher G.H. The place of irradiation in the management of metastatic neck disease. Front Radiat Ther Oncol 22 (1988) 111-120
30. Frank D.K., Hu K.S., Culliney B.E., Persky M.S., Nussbaum M., Schantz S.P., et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope 115 (2005) 1015-1020
31. Garden A., and KK. A. Radiotherapy for head and neck: indications and techniques. 2nd ed (2002), Lippincott Williams and Wilkins, Philadelphia
32. Garden A.S., Glisson B.S., Ang K.K., Morrison W.H., Lippman S.M., Byers R.M., et al. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol 17 (1999) 2390-2395
33. Garden A.S., Morrison W.H., Rosenthal D.I., Chao K.S., and Ang K.K. Target coverage for head and neck cancers treated with IMRT: review of clinical experiences. Semin Radiat Oncol 14 (2004) 103-109
34. Glatzel M., Buntzel J., Schroder D., Kuttner K., and Frohlich D. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer. Laryngoscope 112 (2002) 1366-1371
35. Goguen L.A., Posner M.R., Tishler R.B., Wirth L.J., Norris C.M., Annino D.J., et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 132 (2006) 526-531
36. Grabenbauer G.G., Rodel C., Ernst-Stecken A., Brunner T., Hornung J., Kittel K., et al. Neck dissection following radiochemotherapy of advanced head and neck cancer--for selected cases only?. Radiother Oncol 66 (2003) 57-63
37. Greven K.M., Williams III D.W., Browne J.D., McGuirt Sr. W.F., White D.R., and D'Agostino Jr. R.B. Radiographic complete response on post treatment CT imaging eliminates the need for adjuvant neck dissection after treatment for node positive head and neck cancer. Am J Clin Oncol 31 (2008) 169-172
38. Greven K.M., Williams III D.W., McGuirt Sr. W.F., Harkness B.A., D'Agostino Jr. R.B., Keyes Jr. J.W., et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23 (2001) 942-946
39. Gupta T., and Agarwal J.P. Planned neck dissection following chemo-radiotherapy in advanced HNSCC. Int Semin Surg Oncol 1 (2004) 6
40. Haddad R.I., Wirth L., and Posner M.R. Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer. Expert Rev Anticancer Ther 3 (2003) 331-338
41. Hehr T., Classen J., Schreck U., Glocker S., Koitschev A., Bamberg M., et al. Selective lymph node dissection following hyperfractionated accelerated radio-(chemo-)therapy for advanced head and neck cancer. Strahlenther Onkol 178 (2002) 363-368
42. Hirsch S.M., Caldarelli D.D., Hutchinson Jr. J.C., Holinger L.D., Murthy A.K., Showell J.L., et al. Concomitant chemotherapy and split-course radiation for cure and preservation of speech and swallowing in head and neck cancer. Laryngoscope 101 (1991) 583-586
43. http://www.rtog.org/members/protocols/0522/0522.pdf.
44. http://www.rtog.org/members/protocols/h0129/h0129.pdf.
45. Hu K.S., Kim A., Frank D., Culliney B., Persky M., Schantz S., et al. Does planned neck dissection for N2/N3 disease provide prognostically important pathologic information?. Int J Radiat Oncol Biol Phys 69 (2007) S445
46. Jeremic B. Adjuvant neck dissection after concurrent chemoradiation for advanced head-and-neck cancer: In: regard to Brizel et al. (Int J Radiat Oncol Biol Phys 2004; 58: 1418-1423). Int J Radiat Oncol Biol Phys 2004; 60:1338.
47. Johnson C.R., Silverman L.N., Clay L.B., and Schmidt-Ullrich R. Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: is postradiotherapy neck dissection necessary?. Radiat Oncol Investig 6 (1998) 52-57
48. Kamat U.R., McIntyre J.F., Lin D.T., Deschler D.G., and Chan A.K. Neck management for node positive oropharyngeal carcinoma: A comparison of planned versus response-based neck dissection. Int J Radiat Oncol Biol Phys 69 (2007) S430
49. Lango M.N., Andrews G.A., Ahmad S., Feigenberg S., Tuluc M., Gaughan J., et al. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: Pattern of pathologic residual carcinoma and prognosis. Head Neck 31 3 (2009) 328-337
50. Lango M.N., Myers J.N., and Garden A.S. Controversies in surgical management of the node-positive neck after chemoradiation. Semin Radiat Oncol 19 (2009) 24-28
51. Lau H., Phan T., Mackinnon J., and Matthews T.W. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 134 (2008) 257-261
52. Lavertu P., Adelstein D.J., Saxton J.P., Secic M., Wanamaker J.R., Eliachar I., et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 19 (1997) 559-566
53. Lee H.J., Zelefsky M.J., Kraus D.H., Pfister D.G., Strong E.W., Raben A., et al. Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma. Int J Radiat Oncol Biol Phys 38 (1997) 995-1000
54. Liauw S.L., Mancuso A.A., Amdur R.J., Morris C.G., Villaret D.B., Werning J.W., et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 24 (2006) 1421-1427
55. Mabanta S.R., Mendenhall W.M., Stringer S.P., and Cassisi N.J. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 21 (1999) 591-594
56. Machtay M., Moughan J., Trotti A., Garden A.S., Weber R.S., Cooper J.S., et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26 (2008) 3582-3589
57. McHam S.A., Adelstein D.J., Rybicki L.A., Lavertu P., Esclamado R.M., Wood B.G., et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?. Head Neck 25 (2003) 791-798
58. Meoz R.T., Fletcher G.H., and Lindberg R.D. Anatomical coverage in elective irradiation of the neck for squamous cell carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys 8 (1982) 1881-1885
59. Narayan K., Crane C.H., Kleid S., Hughes P.G., and Peters L.J. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?. Head Neck 21 (1999) 606-613
60. Nayak J.V., Walvekar R.R., Andrade R.S., Daamen N., Lai S.Y., Argiris A., et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 117 (2007) 2129-2134
61. Nouraei S.A., Upile T., Al-Yaghchi C., Sandhu G.S., Stewart S., Clarke P.M., et al. Role of planned postchemoradiotherapy selective neck dissection in the multimodality management of head and neck cancer. Laryngoscope 118 (2008) 797-803
62. Nutting C., Horlock N., A'Hern R., Searle A., Henk J.M., Rhys-Evans P., et al. Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol 80 (2006) 39-42
63. Ohara K., Tatsuzaki H., Kurosaki Y., Fuji H., Myo M., Itai Y., et al. Metastatic lymph-node clearance from head and neck epidermoid carcinomas following radiotherapy. Acta Oncol 38 (1999) 261-266
64. Ojiri H., Mancuso A., Mendenhall W.M., and Stringer S. Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy. AJNR Am J Neuroradiol 23 (2002) 1627-1631
65. Pellitteri P.K., Ferlito A., Rinaldo A., Shah J.P., Weber R.S., Lowry J., et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?. Head Neck 28 (2006) 166-175
66. Peters L.J., Weber R.S., Morrison W.H., Byers R.M., Garden A.S., and Goepfert H. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 18 (1996) 552-559
67. Porceddu S.V., Jarmolowski E., Hicks R.J., Ware R., Weih L., Rischin D., et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 27 (2005) 175-181
68. Prades J.M., Timoshenko A.P., Schmitt T.H., Delolme M.P., Francoz M., Martin C., et al. Planned neck dissection before combined chemoradiation for pyriform sinus carcinoma. Acta Otolaryngol 128 (2008) 324-328
69. Puri D.R., Chou W., and Lee N. Intensity-modulated radiation therapy in head and neck cancers: dosimetric advantages and update of clinical results. Am J Clin Oncol 28 (2005) 415-423
70. Rengan R., Pfister D.G., Lee N.Y., Kraus D.H., Shah J.P., Shaha A.R., et al. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer. Am J Clin Oncol 31 (2008) 465-469
71. Robbins K.T., Doweck I., Samant S., and Vieira F. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg 131 (2005) 965-969
72. Robbins K.T., Wong F.S., Kumar P., Hartsell W.F., Vieira F., Mullins B., et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125 (1999) 670-675
73. Rogers J.W., Greven K.M., McGuirt W.F., Keyes Jr. J.W., Williams III D.W., Watson N.E., et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?. Int J Radiat Oncol Biol Phys 58 (2004) 694-697
74. Sandhu A., Rao N., Giri S., He F., Karakla D., Wadsworth T., et al. Role and extent of neck dissection for persistent nodal disease following chemo-radiotherapy for locally advanced head and neck cancer: how much is enough?. Acta Oncol 47 (2008) 948-953
75. Sanguineti G., Corvo R., Benasso M., Margarino G., Sormani M., Roncallo F., et al. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck 21 (1999) 223-228
76. Sanguineti G., Corvo R., Sormani M.P., Benasso M., Numico G., Bacigalupo A., et al. Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma: predictive factors of outcome. Int J Radiat Oncol Biol Phys 44 (1999) 139-147
77. Santos A.B., Cernea C.R., Inoue M., and Ferraz A.R. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution. Arch Otolaryngol Head Neck Surg 132 (2006) 79-81
78. Schechter N.R., Gillenwater A.M., Byers R.M., Garden A.S., Morrison W.H., Nguyen L.N., et al. Can positron emission tomography improve the quality of care for head-and-neck cancer patients?. Int J Radiat Oncol Biol Phys 51 (2001) 4-9
79. Schwartz D.L., Rajendran J., Yueh B., Coltrera M.D., Leblanc M., Eary J., et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 130 (2004) 1361-1367
80. Sewall G.K., Palazzi-Churas K.L., Richards G.M., Hartig G.K., and Harari P.M. Planned postradiotherapy neck dissection: Rationale and clinical outcomes. Laryngoscope 117 (2007) 121-128
81. Simon C., Goepfert H., Rosenthal D.I., Roberts D., El-Naggar A., Old M., et al. Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol 263 (2006) 313-318
82. Steinkamp H.J., Hosten N., Richter C., Schedel H., and Felix R. Enlarged cervical lymph nodes at helical CT. Radiology 191 (1994) 795-798
83. Stenson K.M., Haraf D.J., Pelzer H., Recant W., Kies M.S., Weichselbaum R.R., et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 126 (2000) 950-956
84. Stenson K.M., Huo D., Blair E., Cohen E.E., Argiris A., Haraf D.J., et al. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope 116 (2006) 33-36
85. Strasser M.D., Gleich L.L., Miller M.A., Saavedra H.I., and Gluckman J.L. Management implications of evaluating the N2 and N3 neck after organ preservation therapy. Laryngoscope 109 (1999) 1776-1780
86. Thariat J., Ahamad A., Garden A.S., Allen P.K., Morrison W.H., Rosenthal D., et al. Oral presentation: Prediction of neck dissection (ND) requirement following definitive radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC). Int J Radiat Oncol Biol Phys 66 (2006) S17-S18
87. Thorwarth D., Eschmann S.M., Holzner F., Paulsen F., and Alber M. Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients. Radiother Oncol 80 (2006) 151-156
88. van den Brekel M.W. Lymph node metastases: CT and MRI. Eur J Radiol 33 (2000) 230-238
89. Vedrine P.O., Thariat J., Hitier M., Janot F., Kaminsky M.C., Makeieff M., et al. Need for neck dissection after radiochemotherapy? A study of the French GETTEC Group. Laryngoscope 118 10 (2008) 1775-1780
90. Vergeer M.R., Doornaert P., Leemans C.R., Buter J., Slotman B.J., and Langendijk J.A. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol 79 (2006) 39-44
91. Westra W.H., Forastiere A.A., Eisele D.W., and Lee D.J. Squamous cell granulomas of the neck: histologic regression of metastatic squamous cell carcinoma following chemotherapy and/or radiotherapy. Head Neck 20 (1998) 515-521
92. Wolf G.T., and Fisher S.G. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 102 (1992) 934-939
93. Yao M, Buatti JM, Dornfeld KJ, Graham MM, Smith RB, Funk GF, et al. Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer? In: regard to Rogers et al. (Int J Radiat Oncol Biol Phys 2004; 58:694-697). Int J Radiat Oncol Biol Phys 2005; 61:306-7; author reply 7.
94. Yao M., Graham M.M., Hoffman H.T., Smith R.B., Funk G.F., Graham S.M., et al. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 59 (2004) 1001-1010
95. Yao M., Hoffman H.T., Chang K., Funk G.F., Smith R.B., Tan H., et al. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?. Int J Radiat Oncol Biol Phys 68 (2007) 707-713
96. Yao M., Smith R.B., Hoffman H.T., Funk G.F., Lu M., Menda Y., et al. Clinical significance of postradiotherapy [(18)F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer. A long-term outcome report. Int J Radiat Oncol Biol Phys 74 1 (2009) 9-14 [Epub 2008]
97. Yeung A.R., Liauw S.L., Amdur R.J., Mancuso A.A., Hinerman R.W., Morris C.G., et al. Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection?. Cancer 112 (2008) 1076-1082
98. Yovino S., Settle K., Taylor R., Wolf J., Kwok Y., Cullen K., et al. Can adjuvant neck dissection be deferred in locally advanced head and neck cancer patients with complete response to definitive chemoradiotherapy?. Int J Radiat Oncol Biol Phys 69 (2007) S15
99. Zhou J., Goenka A., Garg R., Richardson R., Forastiere A., Califano J., et al. Optimal management of the neck in patients with locoregionally advanced oropharyngeal carcinoma:comparison of preradiotherapy neck dissection. Postradiotherapy neck dissection or observation. Int J Radiat Oncol Biol Phys 69 (2007) S414